Department of Surgery, Emory University School of Medicine, Atlanta, GA, USA.
Department of Surgery, Texas Tech University Health Sciences Center, El Paso, TX, USA.
HPB (Oxford). 2022 Sep;24(9):1577-1584. doi: 10.1016/j.hpb.2022.03.018. Epub 2022 Apr 4.
The impact of patient frailty on post-hepatectomy outcomes is not well studied. We hypothesized that patient frailty is a strong predictor of 30-day post-hepatectomy complications.
The liver-targeted National Surgical Quality Improvement Program (NSQIP) database for 2014-2019 was reviewed. A validated modified frailty index (mFI) was used.
A total of 24,150 hepatectomies were reviewed. Worsening frailty was associated with increased incidence of Clavien-Dindo grade IV complications (mFI 0, 1, 2, 3, 4 was 3.9%, 6.3%, 10%, 8.1%, 50% respectively; p < 0.001). Minimally invasive hepatectomies had a lower rate of Clavien-Dindo grade IV complications for non-frail (Laparoscopic: 1%, Robotic: 2.6%, Open: 4.6%; p < 0.001) and frail patients (Laparoscopic: 3%, Robotic: 2.3%, Open: 7.7%; p < 0.001). Frail patients experienced higher incidence of post-hepatectomy liver failure (5.4% vs 4.1% for non-frail; p < 0.001) and grade C liver failure (28% vs 21.1% for non-frail; p = 0.03). Incorporating mFI to Albumin-Bilirubin score (ALBI) improved its ability to predict Clavien-Dindo grade IV complications (AUC improved from 0.609 to 0.647; p < 0.001) and 30-day mortality (AUC improved from 0.663 to 0.72; p < 0.001).
Worsening frailty correlates with increased incidence of Clavien-Dindo grade IV complications post-hepatectomy, whereas minimally invasive approaches decrease this risk. Incorporating frailty assessment to ALBI improves its ability to predict major postoperative complications and 30-day mortality.
患者虚弱对肝切除术后结局的影响尚未得到充分研究。我们假设患者虚弱是术后 30 天并发症的强烈预测因素。
回顾了 2014 年至 2019 年的肝靶向国家手术质量改进计划(NSQIP)数据库。使用了经过验证的改良虚弱指数(mFI)。
共回顾了 24150 例肝切除术。虚弱程度恶化与 Clavien-Dindo 分级 IV 并发症发生率增加相关(mFI 0、1、2、3、4 分别为 3.9%、6.3%、10%、8.1%、50%;p<0.001)。对于非虚弱患者(腹腔镜:1%,机器人:2.6%,开放:4.6%;p<0.001)和虚弱患者(腹腔镜:3%,机器人:2.3%,开放:7.7%;p<0.001),微创肝切除术的 Clavien-Dindo 分级 IV 并发症发生率较低。虚弱患者肝切除术后肝功能衰竭的发生率较高(5.4% vs 非虚弱患者 4.1%;p<0.001)和 C 级肝功能衰竭(28% vs 非虚弱患者 21.1%;p=0.03)。将 mFI 纳入白蛋白-胆红素评分(ALBI)可提高其预测 Clavien-Dindo 分级 IV 并发症(AUC 从 0.609 提高到 0.647;p<0.001)和 30 天死亡率(AUC 从 0.663 提高到 0.72;p<0.001)的能力。
虚弱程度恶化与肝切除术后 Clavien-Dindo 分级 IV 并发症发生率增加相关,而微创方法可降低这种风险。将虚弱评估纳入 ALBI 可提高其预测主要术后并发症和 30 天死亡率的能力。